Ms. Fino drives MassBiologics internal programs and CDMO services at the organization’s two FDA and EMA commercially approved gene therapy and vaccine manufacturing sites.  Ms. Fino has over 30 years of experience as biotech executive. She was senior vice president for manufacturing operations for Protein Sciences Corp, and became the Site Head of Industrial Operations, Meriden CT and Pearl River NY, after Sanofi’s 2017 acquisition of Protein Sciences. Previously, she worked for 16 years at Wyeth Pharmaceuticals now Pfizer, Inc., in a variety of senior roles. Ms. Fino earned an undergraduate degree in biochemical engineering at The Autonomous University of Aguascalientes in Mexico and a Master of Business Administration at MIT.

Talks

• Vaccine manufacturing perspectives for process and technology developers through the product life cycle. Insights and approaches from different case studies.